Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
01 December 2017Website:
http://www.nrxpharma.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 21 Jun 2024 20:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
Similar companies
What type of business is NRx Pharmaceuticals?
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
What sector is NRx Pharmaceuticals in?
NRx Pharmaceuticals is in the Healthcare sector
What industry is NRx Pharmaceuticals in?
NRx Pharmaceuticals is in the Biotechnology industry
What country is NRx Pharmaceuticals from?
NRx Pharmaceuticals is headquartered in United States
When did NRx Pharmaceuticals go public?
NRx Pharmaceuticals initial public offering (IPO) was on 01 December 2017
What is NRx Pharmaceuticals website?
https://www.nrxpharma.com
Is NRx Pharmaceuticals in the S&P 500?
No, NRx Pharmaceuticals is not included in the S&P 500 index
Is NRx Pharmaceuticals in the NASDAQ 100?
No, NRx Pharmaceuticals is not included in the NASDAQ 100 index
Is NRx Pharmaceuticals in the Dow Jones?
No, NRx Pharmaceuticals is not included in the Dow Jones index
When does NRx Pharmaceuticals report earnings?
Next earnings report date is not announced yet